Trials / Unknown
UnknownNCT04416464
Quality of Life and Patient-centered Outcomes After ICU Admission for COVID-19
Quality of Life and Long-term Outcomes in Patients With Pneumonia Associated With SARS-Cov2 Infection, Survivors of Intensive Care Units: a Prospective Multicenter Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 280 (actual)
- Sponsor
- Universidade do Porto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients suffering from pneumonia due to SARS-CoV-2 infection, after admission to the Intensive Care Unit (ICU), are susceptible to development of various functional sequelae, increased risk of chronic diseases, increased mortality rates and existence of relevant impacts on their quality of life in the months and years that follow the ICU admission. The present study aims to assess the determinants of health-related quality of life and patient-centered long-term outcomes among patients recovered from SARS-COV-2 pneumonia, after discharge from the ICU, its determinants and predictors, in Portugal. It is a multicenter prospective cohort study of adult patients admitted at the ICU due to proven or suspected SARS-CoV-2 infection, included 90 days after discharge from the ICU. The primary outcome is one-year health-related quality of life assessed by the EQ-5D-3L. The secondary outcomes are all-cause mortality, rehospitalizations, return to work or study, the degree of dependence and functional capacity, symptoms of anxiety, depression and post-traumatic stress, level of physical activity and cognitive, renal and respiratory functions after ICU discharge. Investigators will collect data by means of structured telephone interviews, at a 12 months follow up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | COVID-19 Pneumonia | Pneumonia due to proven or suspected SARS-Cov-2 infection |
Timeline
- Start date
- 2020-06-15
- Primary completion
- 2021-07-31
- Completion
- 2022-10-01
- First posted
- 2020-06-04
- Last updated
- 2021-09-10
Locations
3 sites across 1 country: Portugal
Source: ClinicalTrials.gov record NCT04416464. Inclusion in this directory is not an endorsement.